These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10376183)

  • 21. [Practical ECG problems. Torsade de pointes in an elderly patient].
    Isaza C; Trombert V
    Rev Med Suisse; 2012 May; 8(340):1025. PubMed ID: 22662633
    [No Abstract]   [Full Text] [Related]  

  • 22. Earthquake-Induced Torsade de Pointes in Long-QT Syndrome.
    Nakagawa S; Aiba T; Nakajima K; Kataoka N; Kamakura T; Wada M; Ishibashi K; Yamagata K; Inoue Y; Miyamoto K; Nagase S; Noda T; Miyamoto Y; Yasuda S; Shimizu W; Kusano K
    Circ J; 2019 Aug; 83(9):1968. PubMed ID: 30842358
    [No Abstract]   [Full Text] [Related]  

  • 23. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early afterdepolarizations, U waves, and torsades de pointes.
    Wu J; Wu J; Zipes DP
    Circulation; 2002 Feb; 105(6):675-6. PubMed ID: 11839619
    [No Abstract]   [Full Text] [Related]  

  • 25. [Sotalol-induced torsade de pointes tachycardia in a 15-month-old infant].
    Sasse M; Paul T; Bergmann P; Kallfelz HC
    Z Kardiol; 1995 Oct; 84(10):863-6. PubMed ID: 7502575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Torsades de Pointes: a rare complication of an extra-adrenal pheochromocytoma.
    Methe H; Hinterseer M; Wilbert-Lampen U; Beckmann BM; Steinbeck G; Kääb S
    Hypertens Res; 2007 Dec; 30(12):1263-6. PubMed ID: 18344633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ranolazine on torsades de pointes tachycardias in a healthy isolated rabbit heart model.
    Sossalla S; Wallisch N; Toischer K; Sohns C; Vollmann D; Seegers J; Lüthje L; Maier LS; Zabel M
    Cardiovasc Ther; 2014 Aug; 32(4):170-7. PubMed ID: 24785406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Torsades de pointes from terfenadine and sotalol given in combination.
    Feroze H; Suri R; Silverman DI
    Pacing Clin Electrophysiol; 1996 Oct; 19(10):1519-21. PubMed ID: 8904547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
    Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sotalol and torsades de pointes ventricular tachycardia].
    Petersen HH; Sandøe E
    Ugeskr Laeger; 1996 May; 158(19):2711-6. PubMed ID: 8744073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A practical approach to torsade de pointes.
    Roden DM
    Clin Cardiol; 1997 Mar; 20(3):285-90. PubMed ID: 9068917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastroenteritis with severe consequences: a case of sotalol-induced torsades de pointes.
    Michiels V; Miljoen H; Vrints C
    Acta Cardiol; 2009 Dec; 64(6):839-42. PubMed ID: 20128168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refractory torsade de pointes induced by terlipressin (Glypressin).
    Jao YTFN
    Int J Cardiol; 2016 Nov; 222():135-140. PubMed ID: 27494726
    [No Abstract]   [Full Text] [Related]  

  • 35. [Torsade de Pointes tachycardia during sotalol treatment of a patient with normal potassium levels].
    Appel JM; Sigurd B
    Ugeskr Laeger; 1996 Jul; 158(28):4093-4. PubMed ID: 8701528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Something Old, Something New: Reinventing Antiarrhythmic Drug Loading With Intravenous Sotalol.
    Savona SJ; Daoud EG
    JACC Clin Electrophysiol; 2023 Apr; 9(4):565-568. PubMed ID: 37100535
    [No Abstract]   [Full Text] [Related]  

  • 37. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
    Eckardt L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest.
    Haverkamp W; Martinez-Rubio A; Hief C; Lammers A; Mühlenkamp S; Wichter T; Breithardt G; Borggrefe M
    J Am Coll Cardiol; 1997 Aug; 30(2):487-95. PubMed ID: 9247523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sotalol--atrial fibrillation, reduced renal function and sudden death].
    Bathen J; Madsen S
    Tidsskr Nor Laegeforen; 1998 Oct; 118(26):4086-7. PubMed ID: 9844513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Torsade de pointes.
    Bubien R
    Am J Nurs; 1999 Sep; 99(9):36-7. PubMed ID: 10489578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.